Hiroaki Kinoh

3.4k total citations · 1 hit paper
57 papers, 2.8k citations indexed

About

Hiroaki Kinoh is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Hiroaki Kinoh has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Biomaterials. Recurrent topics in Hiroaki Kinoh's work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (14 papers) and Virus-based gene therapy research (13 papers). Hiroaki Kinoh is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (14 papers) and Virus-based gene therapy research (13 papers). Hiroaki Kinoh collaborates with scholars based in Japan, China and United States. Hiroaki Kinoh's co-authors include Motoharu Seiki, Kazunori Kataoka, Masahiro Kajita, Akiko Okada, Yoshifumi Itoh, Hidetoshi Mori, Tadashige Chiba, Horacio Cabral, Xueying Liu and Hiroshi Sato and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Hiroaki Kinoh

55 papers receiving 2.8k citations

Hit Papers

Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and... 2001 2026 2009 2017 2001 200 400 600

Peers

Hiroaki Kinoh
In-San Kim South Korea
Jennifer E. Koblinski United States
Moonsoo M. Jin United States
Emilia S. Olson United States
Hiroaki Kinoh
Citations per year, relative to Hiroaki Kinoh Hiroaki Kinoh (= 1×) peers Janelle L. Lauer‐Fields

Countries citing papers authored by Hiroaki Kinoh

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kinoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kinoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kinoh more than expected).

Fields of papers citing papers by Hiroaki Kinoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kinoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kinoh. The network helps show where Hiroaki Kinoh may publish in the future.

Co-authorship network of co-authors of Hiroaki Kinoh

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kinoh. A scholar is included among the top collaborators of Hiroaki Kinoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kinoh. Hiroaki Kinoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Chun Yin Jerry, Hiroaki Kinoh, Xueying Liu, et al.. (2025). Structurally Dynamic Polyplexes Enhance Sentinel Lymph Node Delivery of Antisense Oligonucleotides to Inhibit Breast Cancer Recurrence and Metastasis. Journal of the American Chemical Society. 147(30). 26286–26297.
2.
Li, Junjie, Kazuko Toh, Panyue Wen, et al.. (2025). Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer. Nature Biomedical Engineering. 1 indexed citations
3.
Yang, Tao, Yuki Mochida, Xueying Liu, et al.. (2021). Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma. Nature Biomedical Engineering. 5(11). 1274–1287. 61 indexed citations
4.
Kinoh, Hiroaki, Horacio Cabral, Sabina Quader, et al.. (2021). Efficacy of pH-Sensitive Nanomedicines in Tumors with Different c-MYC Expression Depends on the Intratumoral Activation Profile. ACS Nano. 15(3). 5545–5559. 20 indexed citations
5.
Lübtow, Michael M., Sabina Quader, Elisabeth Jeanclos, et al.. (2020). In Vitro Blood–Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D Models. Molecular Pharmaceutics. 17(6). 1835–1847. 35 indexed citations
6.
Dirisala, Anjaneyulu, Satoshi Uchida, Kazuko Toh, et al.. (2020). Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines. Science Advances. 6(26). eabb8133–eabb8133. 61 indexed citations
7.
Kinoh, Hiroaki, Sabina Quader, Xueying Liu, et al.. (2020). Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative Glioblastoma. ACS Nano. 14(8). 10127–10140. 58 indexed citations
8.
Cabral, Horacio, Hiroaki Kinoh, & Kazunori Kataoka. (2020). Tumor-Targeted Nanomedicine for Immunotherapy. Accounts of Chemical Research. 53(12). 2765–2776. 93 indexed citations
9.
Tockary, Theofilus A., Anjaneyulu Dirisala, Qixian Chen, et al.. (2019). Single-Stranded DNA-Packaged Polyplex Micelle as Adeno-Associated-Virus-Inspired Compact Vector to Systemically Target Stroma-Rich Pancreatic Cancer. ACS Nano. 13(11). 12732–12742. 35 indexed citations
10.
Yi, Yu, Hyun Jin Kim, Meng Zheng, et al.. (2019). Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells. Journal of Controlled Release. 295. 268–277. 101 indexed citations
11.
Ke, Wendong, Junjie Li, Fathelrahman Mohammed, et al.. (2019). Therapeutic Polymersome Nanoreactors with Tumor-Specific Activable Cascade Reactions for Cooperative Cancer Therapy. ACS Nano. 13(2). 2357–2369. 230 indexed citations
12.
Makino, Junichiro, Horacio Cabral, Yutaka Miura, et al.. (2015). cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis. Journal of Controlled Release. 220(Pt B). 783–791. 30 indexed citations
13.
Chen, Qixian, Kensuke Osada, Takehiko Ishii, et al.. (2012). Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors. Biomaterials. 33(18). 4722–4730. 56 indexed citations
14.
Komaru, Atsushi, Yasuji Ueda, Kumi Yoshida, et al.. (2009). Sustained and NK/CD4+ T Cell-Dependent Efficient Prevention of Lung Metastasis Induced by Dendritic Cells Harboring Recombinant Sendai Virus. The Journal of Immunology. 183(7). 4211–4219. 31 indexed citations
15.
Inoue, Hiroyuki, Mutsunori Iga, Shinji Okano, et al.. (2008). Non‐transmissible Sendai virus encoding granulocyte macrophage colony‐stimulating factor is a novel and potent vector system for producing autologous tumor vaccines. Cancer Science. 99(11). 2315–2326. 15 indexed citations
16.
Kinoh, Hiroaki. (2007). New cancer therapy using genetically-engineered oncolytic Sendai virus vector. Frontiers in bioscience. 13(13). 2327–2327. 18 indexed citations
17.
18.
Abé, Hiroyuki, Hiroaki Kinoh, & Norio Suzuki. (1994). Seasonal variations in the production of the egg-jelly macromolecule, a fucose sulphate glycoconjugate, by the accessory cells in the ovary of the sea urchin Hemicentrotus pulcherrimus. Development Genes and Evolution. 203(7-8). 402–410. 2 indexed citations
19.
Abe, H, Hiroaki Kinoh, Taneaki Oikawa, & Noriko Suzuki. (1991). SYNTHESIS OF FUCOSE SULFATE GLYCOCONJUGATE, WHICH INDUCES THE ACROSOME REACTION. DURING OOGENESIS.(Developmental Biology)(Proceedings of the Sixty-Second Annual Meeting of the Zoological Society of Japan). ZOOLOGICAL SCIENCE. 8(6). 1094. 1 indexed citations
20.
Shimizu, Takeshi, Hiroaki Kinoh, Masaaki Yamaguchi, & Norio Suzuki. (1990). Purification and Characterization of the Egg Jelly Macromolecules, Sialoglycoprotein and Fucose Sulfate Glycoconjugate, of the Sea Urchin Hemicentrotus Pulcherrimus. Development Growth & Differentiation. 32(5). 473–487. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026